Pharmaceutical Technology on MSN
EU’s Joint Clinical Assessment system still finding its footing
With publication of the first JCA report imminent, procedural and methodological challenges persist.
Roger E. Barton and Brigette Renaud of Barton LLP discuss new Department of Labor proposed regulations on "alternative ...
Prescribing information for the RSV prefusion F subunit-based vaccine includes a warning to inform pregnant women about a ...
Alternative methods to the use of animals in pharmaceutical testing are becoming more used and accepted. Laura Lotfi of ...
Discusses Modulation and Combination Strategies in ER-Positive Metastatic Breast Cancer and the Role of Lasofoxifene April 29, ...
Wagner, Reish and Fleckner break down the proposed alternatives rule, pending Supreme Court review and a class-action curveball out of the Fourth Circuit ...
Obexelimab Phase 3 win, SLE catalyst, pipeline updates (ZB014, orelabrutinib), and cash runway—read now. Click for a ZBIO ...
This third iteration of the Lancet Countdown on health and climate change in Europe report systematically tracks the health effects of climate change adaptation and mitigation action, economics and ...
Objectives To assess physical and mental symptoms by ethnicity of a UK Armed Forces cohort. Design A retrospective, pooled ...
Evidence is reassuring, but risk-benefit discussions with patients should reflect broader safety profile Anxiety and insomnia ...
There was a survival advantage to having hospitals with mechanical circulatory support (MCS) escalation capabilities treat ...
Peer group comparisons are often used to provide context — but they come with their own complexities. Saying you’re ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results